Zhi Qiang Chen

US Patent:

20010044339, Nov 22, 2001

Filed:

Feb 20, 2001

Appl. No.:

09/789834

Inventors:

Angel Cordero - Brooklyn NY, US
Nicholas Gonzalez - Hicksville NY, US
Zhi Chen - Brooklyn NY, US
Roger Campos - Brentwood NY, US
Alfred Polanco - Glendale NY, US
Daniel Melfi - Medford NY, US
Nicodemo Schipano - San Bruno CA, US
Mimoun Ouchaou - Freeport NY, US

International Classification:

A63F009/24
G06F017/00
G06F019/00

US Classification:

463/042000, 463/040000

Abstract:

A multi-player computer game, system and development method that facilitate multi-player game play between and among various hardware platforms employing various operating systems and communication protocols. Multi-player game play between and among a plurality of players is now possible regardless of the hardware platform, communication protocol, and operating system of each of the player's computing devices. Players having different hardware and software configurations on their respective computing devices and communicating using various communication protocols may engage each other in multi-player game play. New application modules may be developed using a cross platform core and other foundation technologies to simplify and speed software development. Coding to a specific operating system or hardware device or protocol is no longer required.

US Patent:

20150307461, Oct 29, 2015

Filed:

Jul 7, 2015

Appl. No.:

14/792722

Inventors:

Joseph A. Bilotta - Nutley NJ, US
Zhi Chen - Livingston NJ, US
Elbert Chin - San Mateo CA, US
Qingjie Ding - Bridgewater NJ, US
Shawn D. Erickson - Leonia NJ, US
Stephen D. Gabriel - Morristown NJ, US
Klaus G. Klumpp - Palo Alto CA, US
Han Ma - Passaic NJ, US
Eric Mertz - Fair Lawn NJ, US
Jean-Marc Plancher - Hagenthal-le-Bas, FR
Robert J. Weikert - Clifton NJ, US

Assignee:

Hoffmann-La Roche Inc. - Nutley NJ

International Classification:

C07D 249/14
C07D 403/12
A61K 31/5377
A61K 31/4196
A61K 38/21

Abstract:

The present invention discloses compounds of Formula I:wherein the variables in Formula I are defined as described herein. Also disclosed are pharmaceutical compositions containing such compounds and methods for using the compounds of Formula I in the prevention or treatment of HCV infection.